📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion

📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion

Share this post

📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion
📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion
OptiBiotix Health PLC

OptiBiotix Health PLC

Is OptiBiotix Being Taken for a Ride? A Shareholder’s Perspective on the LeanBiome Labelling Discrepancy

🐝 Elric Langton's avatar
🐝 Elric Langton
Jun 13, 2025
∙ Paid
11

Share this post

📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion
📈 LEMMING INVESTOR RESEARCH by 📈Small Company Champion
OptiBiotix Health PLC
8
8
Share

By Elric Langton | 13 June 2025

Mike, Alex, and I are financially interested in SkinBioTherapeutics and OptiBiotix Health.

As a shareholder in OptiBiotix Health, I have taken a keen interest in the launch and promotion of LeanBiome, a supplement described in the Lean for Good press release dated 23 May 2025 as a “clinically researched gut health supplement” designed to “support natural weight loss through probiotic and prebiotic synergy.” Developed using OptiBiotix’s unique microbiome technology, LeanBiome® was promoted as the first formula of its kind to combine nine ‘lean bacteria’ species with Greenselect Phytosome®, a patented and caffeine-free green tea extract.

Compare the marketing blurbs.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 📈 🐝 Small Company Champion - Small Company Media Ltd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share